Nautilus Biotechnology, Inc.

Developing a proteomics platform for single-molecule analysis to advance life sciences research.

NAUT | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 2701 EASTLAKE AVE EAST, 98102 SEATTLE
Website:: https://www.nautilus.bio/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Nautilus Biotechnology, Inc. is a development-stage life sciences company focused on revolutionizing the field of proteomics. The company is creating a platform to analyze and quantify the human proteome with single-molecule resolution at a massive scale. Its proprietary technology leverages a method called Iterative Mapping to provide high-resolution views of billions of individual protein molecules and their modified forms (proteoforms). Nautilus aims to democratize proteomics by offering an integrated system with accessible workflows and cloud-based analysis tools. The platform is designed to accelerate breakthroughs in drug discovery, biomarker identification, and fundamental biological research by providing clearer insights into the mechanisms of health and disease.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Nautilus Biotechnology, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Nautilus Biotechnology, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Nautilus Biotechnology, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
MAIA Biotechnology, Inc. Developing telomere-targeting immuno-oncology therapies for difficult-to-treat cancers.	United States of America	MAIA
Mare Nostrum Comprehensive HR solutions provider for recruitment, temporary work, training, and wage portage.	France	ALMAR
Marubeni Construction Material Lease Co.,Ltd. Leases and sells temporary steel materials and offers engineering for major construction projects.	Japan	9763
MATCHING SERVICE JAPAN CO.,LTD. Specialized recruitment firm connecting legal, finance, and accounting experts with top companies.	Japan	6539
Material Group inc. A professional services firm offering PR consulting, marketing, and brand strategy.	Japan	156A
Medesis Pharma S.A. Develops therapies for CNS disorders and radiation exposure via a drug delivery platform.	France	ALMDP
MEDICINOVA INC Developing small-molecule therapies for neurological, respiratory, and fibrotic diseases.	United States of America	MNOV
Medicofarma Biotech Spolka Akcyjna A biotech R&D company developing innovative drugs and devices with a focus on oncology therapies.	Poland	MDB
Medpace Holdings, Inc. Global CRO providing full-service clinical development to biotech, pharma & medical device industries.	United States of America	MEDP
MedPacto, Inc. Develops biomarker-based precision therapies for oncology and other incurable diseases.	South Korea	235980